Proteomics

Dataset Information

0

Escherichia coli killing by Shigella sonnei is mediated by colicins found in epidemiologically successful sublineages


ABSTRACT: Shigella sonnei as an enteric pathogen, can benefit from outcompeting gut commensals such as Escherichia coli and there can be several mechanisms that assist in interbacterial competition. It is, therefore, important to understand these mechanisms as they provide insights into the interactions of these pathogens in the complex environment they exist. We used our novel Bulk Phenotyping of Epidemiological Replicates (BPER) pipeline combined with bacterial Genome Wide Association Studies (GWAS) on a previously described real-world collection of S. sonnei isolates (n=165) to demonstrate the vital role that colicins could have played in shaping the observed epidemiology of S. sonnei. We then used targeted mass spectrometry on representative S. sonnei isolates to detect colicin sequences in cell free supernatants, which further validated our BPER results to suggest the vital role of colicins. Here, we also introduce BPER as an epidemiologically relevant way of phenotypic testing in the laboratory where the phenotypic results can be interpreted with much more relevance to the effects of those phenotypes in natural settings.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Shigella Sonnei

SUBMITTER: Lauriane Kuhn  

LAB HEAD: Kate Baker

PROVIDER: PXD036656 | Pride | 2023-10-24

REPOSITORIES: Pride

altmetric image

Publications

Escherichia coli killing by epidemiologically successful sublineages of Shigella sonnei is mediated by colicins.

De Silva P Malaka PM   Bennett Rebecca J RJ   Kuhn Lauriane L   Ngondo Patryk P   Debande Lorine L   Njamkepo Elisabeth E   Ho Brian B   Weill François-Xavier FX   Marteyn Benoît S BS   Jenkins Claire C   Baker Kate S KS  

EBioMedicine 20231006


<h4>Background</h4>Shigella sp. are enteric pathogens which causes >125 million cases of shigellosis annually. S. sonnei accounts for about a quarter of those cases and is increasingly prevalent in industrialising nations. Being an enteric pathogen, S. sonnei benefits from outcompeting gut commensals such as Escherichia coli to establish itself and cause disease. There are numerous mechanisms that bacterial pathogens use to outcompete its rivals including molecules called colicins. A Type 6 Secr  ...[more]

Similar Datasets

2012-10-29 | E-BUGS-124 | biostudies-arrayexpress
2010-06-08 | E-GEOD-21966 | biostudies-arrayexpress
| PRJNA93717 | ENA
2011-07-25 | GSE27326 | GEO
2013-02-13 | E-GEOD-44268 | biostudies-arrayexpress
| PRJNA164143 | ENA
| S-EPMC7225751 | biostudies-literature
2011-07-24 | E-GEOD-27326 | biostudies-arrayexpress
2013-09-30 | E-GEOD-45714 | biostudies-arrayexpress
2013-09-30 | E-GEOD-45713 | biostudies-arrayexpress